Virtual Library

 x 
My Library Virtual Library FAQ

Start Your Search

Filter Results:

Show Only Available Presentations

  • +

    P47 - Novel Therapeutics and Targeted Therapies - Clinical Trial in Progress

    • Type: Posters
    • Track: Novel Therapeutics and Targeted Therapies
    • Presentations: 18
    • Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
    • +

      P47.15 - A Phase IA Study of Ceritinib + Trametinib in Patients With Advanced ALK- or ROS1- Rearranged NSCLC: Preliminary Results

      00:00 - 00:00  |  Presenter: Matthew Lara

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    IS05 - Industry Symposium Sponsored by Amgen: Advancing the Lung Cancer Landscape with Novel Strategies

    • Type: Industry Supported Symposium
    • Track: N.A.
    • Presentations: 5
    • Moderators:David R. Gandara
    • Coordinates: 9/09/2021, 13:15 - 14:15, Industry Symposium Auditorium via Industry Hub
    • +

      IS05.01 - Welcome and Introductions

      13:15 - 13:20  |  Presenter: David R. Gandara

      • Abstract

      No abstract available for this presentation

    • +

      IS05.02 - The Evolving Biomarker Landscape in Advanced NSCLC

      13:20 - 13:35  |  Presenter: David R. Gandara

      • Abstract

      No abstract available for this presentation

    • +

      IS05.03 - KRASG12C Inhibitors – Ongoing Developments and Clinical Findings in NSCLC

      13:35 - 13:50  |  Presenter: Alexander Spira

      • Abstract

      No abstract available for this presentation

    • +

      IS05.04 - Utilizing the Potential of the BiTE® Immuno-Oncology Platform to Engage DLL3, an Emerging Target in SCLC

      13:50 - 14:05  |  Presenter: Afshin Dowlati

      • Abstract

      No abstract available for this presentation

    • +

      IS05.05 - Discussion

      14:05 - 14:15

      • Abstract

      No abstract available for this presentation

  • +

    ES20 - Caveats, Challenges, and Controversies in Immunotherapy of Lung Cancer: Phase II and Phase III Trials*

    • Type: Education Session
    • Track: Immunotherapy (Phase II/III Trials)
    • Presentations: 5
    *Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.
    • Moderators:David R. Gandara
    • Coordinates: 9/14/2021, 20:30 - 21:05, Program Auditorium
    • +

      ES20.01 - The Statistical Imperatives of Immunotherapy Research

      20:30 - 20:32  |  Presenter: Mary Redman

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      ES20.02 - Charting a New Path: Defining Better Endpoints in Immune Therapy Trials in Lung Cancer

      20:32 - 20:34  |  Presenter: Sanjay Popat

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      ES20.03 - Open and Unanswered Questions for Treatment and Needed Studies: What We Do and Do Not Know

      20:34 - 20:36  |  Presenter: Nick Pavlakis

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      ES20.04 - Challenges to Expand Who Gets Immunotherapy

      20:36 - 20:38  |  Presenter: Lyudmila Bazhenova

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      ES20.05 - Live Discussion with Speakers

      20:38 - 21:05

      • Abstract

      No abstract available for this presentation